Form 4: Hims & Hers CMO Carroll Reports RSU Vesting, Tax Withholding

Hims & Hers Health, Inc. Chief Medical Officer Patrick Harrison Carroll reported the vesting of restricted stock units and subsequent tax-related share disposals.

Summary

• Patrick Harrison Carroll, Chief Medical Officer and Director of Hims & Hers Health, Inc., reported transactions on December 15, 2025.
• Acquired 16,521 shares of Class A Common Stock through the vesting of Restricted Stock Units (RSUs).
• Disposed of 6,500 shares of Class A Common Stock at $36.25 per share to cover tax withholding obligations related to the RSU vesting.
• Following these transactions, Carroll beneficially owns 179,961 shares of Class A Common Stock directly.
• Additionally, Carroll reported the vesting of 8,149, 4,839, and 3,533 derivative Restricted Stock Units from separate grants, which represent a contingent right to receive Class A Common Stock.
• After these derivative transactions, Carroll beneficially owns 32,595, 43,557, and 45,930 RSUs from the respective grants.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The vesting of RSUs is a positive for executive alignment, while the tax-related sale is a routine, neutral event. No significant new information impacting company fundamentals.

Positives

• The vesting of Restricted Stock Units (RSUs) indicates continued alignment of management's interests with shareholders.
• The acquisition of 16,521 shares through RSU vesting increases the Chief Medical Officer's direct ownership in the company.

Negatives

• The disposal of 6,500 shares to cover tax withholding obligations, while standard practice, reduces the direct share count held by the Chief Medical Officer.

Future Outlook

The filing indicates future vesting events for various Restricted Stock Unit grants, with scheduled quarterly installments extending over the next three to four years, aligning executive compensation with long-term company performance.

Industry Context

This routine insider transaction reflects standard executive compensation practices within the healthcare technology sector, where equity awards like RSUs are common tools for aligning management incentives with shareholder value creation. It does not provide specific insights into broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: The vesting and subsequent tax-related sale of shares by a key executive is a routine event. While the issuance of shares from RSU vesting can cause minor dilution, it also aligns management's interests with long-term shareholder value.
• Employees: The RSU vesting schedule demonstrates the company's ongoing equity compensation strategy for its executives.

Next Steps

• Continued quarterly vesting of Restricted Stock Units on March 15, June 15, September 15, and December 15 for various grants over the next 3-4 years.

Key Dates

Keywords

Hims & Hers Health, HIMS, Patrick Harrison Carroll, Chief Medical Officer, Director, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Stock Ownership, Tax Withholding